The first Czechoslovak State institute of
national health was founded after the World War I on the soil of former
agriculture farm in Bohumil. Its main purpose was to develop and produce the
sera and vaccines and control the quality of food and drugs. The health institute
was moved to Prague after the World War II with exception of its manufacturing
division. Vaccines were produced in Bohumil by company Biogena and later Sevac.
After the Velvet revolution, the government decided on the construction of the Human
plasma fractionation facility. The project was never finished and the site was
purchased by company Baxter in 2001. The influenza Vaccines were produced in
Bohumil between 2003 and 2015 based on the advanced serum free Vero cell
technology. Company Nanotherapeutics acquired the site after the production
program termination. Nanotherapeutics sold the site together with the
Vero cell license for IPV production to newly established Praha Vaccines.